Driven To Cure – Built to Drive – DTC
Driven To Cure is a 501(c)(3) nonprofit created by Andrew Lee and supported by his Brother Tommy Lee who also manages Crustless Media. Driven To Cure’s mission is to raise awareness about rare kidney cancers like HLRCC.
With the support from family and friends, it is amazing what these two brothers have accomplished over the past year. Driven To Cure raised $200,000(US) and has donated to the Foundation for the National Institutes of Health (FNIH), The donation will support the research of W. Marston Linehan, M.D., Chief of Urologic Surgery and the Urologic Oncology Branch, Center for Cancer Research, at the National Cancer Institute (NCI), who is developing novel approaches to treat multiple forms of kidney cancer. Since SEMA 2016, Driven To Cure has received donations and support from over 33 different countries, that’s not a typo, 33 COUNTRIES.
The amount of press and coverage to raise awareness is overwhelming. You can read more about the donation raised for FNIH here: http://fnih.org/news/press-releases/driven-to-cure
Bethesda Magazine also featured Andrew and his, “souped-up sports car” in December 2016. You can read more here: http://www.bethesdamagazine.com/Bethesda-Beat/Web-2016/Georgetown-Prep-Grad-Raises-200000-for-NIH-Cancer-Research-with-Souped-Up-Sports-Car/
To learn more about Andrew’s dream of building his dream car and raising awareness, check out Andrew’s documentary video below. Taking the GTR to the next level to raise awareness and bringing together the car community and accomplishing so much in just the past year is amazing, all while battling and kicking cancers ass!
Driven To Cure
F CANCR Liberty Walk GTR (Documentary) – Crustless Media
How can you help?
To help raise awareness and support Driven To Cure:
Continuing to Spread Awareness
Car Throttle Interview
YouTuber: ThatDudeinBlue Interview
Andrew’s Dream Car Nissan GTR
Build credit and sponsors:
What is HLRCC?
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a disorder in which affected individuals tend to develop benign tumors containing smooth muscle tissue (leiomyomas) in the skin and, in females, the uterus. This condition also increases the risk of kidney cancer.
In this disorder, growths on the skin (cutaneous leiomyomas) typically develop in the third decade of life. Most of these growths arise from the tiny muscles around the hair follicles that cause “goosebumps”. They appear as bumps or nodules on the trunk, arms, legs, and occasionally on the face. Cutaneous leiomyomas may be the same color as the surrounding skin, or they may be darker. Some affected individuals have no cutaneous leiomyomas or only a few, but the growths tend to increase in size and number over time. Cutaneous leiomyomas are often more sensitive than the surrounding skin to cold or light touch, and may be painful.
Most women with HLRCC also develop uterine leiomyomas (fibroids). While uterine fibroids are very common in the general population, women with HLRCC tend to have numerous large fibroids that appear earlier than in the general population.
Approximately 10 percent to 16 percent of people with HLRCC develop a type of kidney cancer called renal cell cancer. The signs and symptoms of renal cell cancer may include lower back pain, blood in the urine, or a mass in the kidney that can be felt upon physical examination. Some people with renal cell cancer have no symptoms until the disease is advanced. The average age at which people with HLRCC are diagnosed with kidney cancer is in their forties.
This disorder, especially if it appears in individuals or families without renal cell cancer, is also sometimes called multiple cutaneous leiomyomatosis (MCL) or multiple cutaneous and uterine leiomyomatosis (MCUL). (Source: ghr.nlm.nih.gov)
Follow Driven To Cure
Driven To Cure: